1 Department of Clinical Dentistry, Center for Clinical Dental Research, University of Bergen , Bergen, Norway .
2 Department of Oral and Maxillofacial Surgery, University of Bergen and Haukeland University Hospital , Bergen, Norway .
Tissue Eng Part B Rev. 2018 Aug;24(4):300-316. doi: 10.1089/ten.TEB.2017.0429. Epub 2018 Mar 8.
Reconstruction of degenerated temporomandibular joint (TMJ) structures remains a clinical challenge. Tissue engineering (TE) is a promising alternative to current treatment options, where the TMJ is either left without functional components, or replaced with autogenous, allogeneic, or synthetic grafts. The objective of this systematic review was to answer the focused question: in experimental animal models, does the implantation of biomaterial scaffolds loaded with cells and/or growth factors (GFs) enhance regeneration of the discal or osteochondral TMJ tissues, compared with scaffolds alone, without cells, or GFs? Following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis) guidelines, electronic databases were searched for relevant controlled preclinical in vivo studies. Thirty studies reporting TMJ TE strategies in both small (rodents, rabbits; n = 25) and large animals (dogs, sheep, goats; n = 5) reporting histological and/or radiographic outcomes were included. Twelve studies reported ectopic (subcutaneous) implantation models in rodents, whereas 18 studies reported orthotopic, surgically induced defect models in large animals. On average, studies presented with an unclear-to-high risk of bias. In most studies, mesenchymal stem cells or chondrocytes were used in combination with either natural or synthetic polymer scaffolds, aiming for either TMJ disc or condyle regeneration. In summary, the overall preclinical evidence (ectopic [n = 6] and orthotopic TMJ models [n = 6]) indicate that addition of chondrogenic and/or osteogenic cells to biomaterial scaffolds enhances the potential for TMJ tissue regeneration. Standardization of animal models and quantitative outcome evaluations (biomechanical, biochemical, histomorphometric, and radiographic) in future studies, would allow more reliable comparisons and increase the validity of the results.
重建退变的颞下颌关节(TMJ)结构仍然是一个临床挑战。组织工程(TE)是目前治疗方法的一种有前途的替代方法,其中 TMJ 要么没有功能性成分,要么用自体、同种异体或合成移植物替代。本系统评价的目的是回答一个焦点问题:在实验动物模型中,与单独支架(无细胞或生长因子)相比,植入负载细胞和/或生长因子(GFs)的生物材料支架是否能增强盘状或骨软骨 TMJ 组织的再生?根据 PRISMA(系统评价和荟萃分析的首选报告项目)指南,检索电子数据库以获取相关的对照性体内临床前研究。纳入了 30 项报告 TMJ TE 策略的研究,这些研究分别在小型(啮齿动物、兔子;n=25)和大型动物(狗、绵羊、山羊;n=5)中报告了组织学和/或影像学结果。12 项研究报告了啮齿动物异位(皮下)植入模型,而 18 项研究报告了大型动物的原位、手术诱导的缺损模型。平均而言,研究的偏倚风险为不清楚到高。在大多数研究中,间充质干细胞或软骨细胞与天然或合成聚合物支架结合使用,旨在实现 TMJ 盘或髁突的再生。总之,总体临床前证据(异位[ n=6]和原位 TMJ 模型[ n=6])表明,将成软骨和/或成骨细胞添加到生物材料支架中可以增强 TMJ 组织再生的潜力。未来研究中,动物模型的标准化和定量结果评估(生物力学、生物化学、组织形态计量学和影像学)将允许更可靠的比较,并提高结果的有效性。